Blood May Reveal the Presence of Inflammatory Bowel Disease Ten Years Before Diagnosis

🔎 Early Signs of Inflammatory Bowel Disease Appear in the Blood Ten Years Before Diagnosis

Scientists have revealed subtle changes in the immune system that can be detected in the blood ten years before a diagnosis of Inflammatory Bowel Disease (Inflammatory Bowel Disease – IBD). These findings point to the possibility of developing blood tests that help with early detection of individuals at risk, and perhaps even determining the likely severity of the disease.

🩺 Inflammatory Bowel Disease: An Overview

Inflammatory Bowel Disease includes chronic disorders such as Crohn’s disease (Crohn’s disease – CD) and ulcerative colitis (ulcerative colitis – UC), which cause ongoing inflammation in the digestive system because of an abnormal immune response. Worsening inflammation leads to damage in the intestines and affects patients’ quality of life.

Researchers believe the disease begins developing inside the body several years before an official diagnosis, but the immune changes at this early stage have remained unclear until now.

🧪 Reviewing Blood Samples Over a Decade

A team of researchers studied 2000 blood serum samples from 500 people, including 200 who developed Crohn’s disease, 200 who developed ulcerative colitis, and 100 who were healthy. Blood samples were available at different times, starting from diagnosis and extending through several periods reaching 10 years before diagnosis.

The researchers analyzed antibody interactions against about 357,000 antigens associated with bacteria, viruses, food, and the immune system itself. Here, the antigens are substances recognized and targeted by immune cells, and the antibodies are the proteins produced by the immune system to recognize these antigens.

A total of 123,980 unique antibodies were identified in the samples under study.

🧬 Immune Differences Between Crohn’s Disease and Ulcerative Colitis

• People who later developed one of the inflammatory bowel diseases had less diversity in antibodies compared with healthy individuals, suggesting a narrower immune response.
• Crohn’s disease was associated with higher antibodies against herpes viruses and flagellin protein, a component of bacteria used for movement.
• The change in antibodies was especially pronounced in complicated Crohn’s cases or those affecting the terminal end of the small intestine (ileum).
• There were gradual declines in antibody responses against encapsulated bacteria before a diagnosis of Crohn’s disease.
• As for those with ulcerative colitis, they had increased antibodies against herpes viruses and autoantigens, while their responses to encapsulated bacteria decreased.

This indicates the existence of different immune signatures and blood signals that distinguish Crohn’s disease from ulcerative colitis even before disease symptoms appear.

🤖 The Role of Artificial Intelligence in Early Disease Prediction

The researchers used machine learning techniques to analyze antibody data in order to distinguish future patients from healthy individuals. The results were promising:

• The model was able to distinguish Crohn’s disease cases from healthy individuals with an accuracy metric (AUC) of 0.90.
• For ulcerative colitis, the accuracy metric was 0.84.
• The model was also able to predict the complicated or simple type of Crohn’s disease 10 years before diagnosis with an accuracy of 0.85.

These indicators strengthen the potential of a blood test based on antibody patterns to identify disease early and tailor treatment options according to the type and severity of the disease.

⚠️ Challenges and Next Steps

Despite the encouraging results, this method still needs more research before it can be adopted as a routine screening test. It is necessary to:

• Confirm these immune signatures in larger and more diverse patient groups.
• Compare the usefulness of antibody analysis with genetic information, clinical examinations, and other blood measurements.
• Develop a blood test that is accurate, practical, and affordable.
• Prove that using this test actually improves patient outcomes through early intervention.

Researchers look forward to future studies that meet these requirements, with the possibility of providing a new tool that enables doctors to anticipate complications and bring the right treatment closer at an early stage.

🏁 Conclusion

This study represents an important step in understanding how inflammatory bowel disease develops from an unknown early stage to an official diagnosis. The immune changes detected in the blood hold the potential to change detection and treatment methods in the future, thereby enhancing early healthcare for patients.

Source: Health & Science News

📚 Related articles

🧠 The Hidden Turning Point in Alzheimer’s Disease That Could Determine the Outcome of Dementia

2026/09/08

The Study Reveals: Depression Affects the Brain’s Ability to Form New Neurons

2026/09/24

Smart Particles Detect Brain Cancer and Target Cells Left Behind After Surgery

2026/09/24